Evidence map›Paper›PMID 28784805›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Histone phosphorylation by TRPM6's cleaved kinase attenuates adjacent arginine methylation to regulate gene expression.

Grigory Krapivinsky, Luba Krapivinsky, Nora E Renthal, Ana Santa-Cruz, Yunona Manasian, David E Clapham

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Epigenetic Regulation of Fungal Secondary Metabolism.Journal of fungi (Basel, Switzerland) · 2024
    Review
  7. TRPM channels in health and disease.Nature reviews. Nephrology · 2024
    Review
  8. Article
  9. Article
  10. Interaction of Calmodulin with TRPM: An Initiator of Channel Modulation.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Hereditary kidney diseases associated with hypomagnesemia.Kidney research and clinical practice · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Transient Receptor Potential Cation Channels in Cancer Therapy.Medical sciences (Basel, Switzerland) · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Grigory KrapivinskyHoward Hughes Medical Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Luba KrapivinskyHoward Hughes Medical Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Nora E RenthalDivision of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Ana Santa-CruzHoward Hughes Medical Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
Yunona ManasianHoward Hughes Medical Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
David E ClaphamHoward Hughes Medical Institute, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115; claphamd@janelia.hhmi.org.
Boston Children's Hospital · USHarvard University · USHoward Hughes Medical Institute · US

Funding

Research in Development Endocrinology and MetabolismT32DK007699 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI JOEL N HIRSCHHORN · 1992 to 2026
$7.1M
Exploring Transient receptor potential melastatin 6 (TRPM6) as a channel-kinase regulator of mineral metabolismF32DK111109 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI RENTHAL, NORA EDWARDS · 2016 to 2016
$39k
Howard Hughes Medical InstituteNIDDK NIH HHS F32 DK111109NIDDK NIH HHS L40 DK110901NIDDK NIH HHS T32 DK007699
6 · The paper itself

Abstract

TRPM6 and TRPM7 are members of the melastatin-related transient receptor potential (TRPM) subfamily of ion channels. Deletion of either gene in mice is embryonically lethal. TRPM6/7 are the only known examples of single polypeptides containing both an ion channel pore and a serine/threonine kinase (chanzyme). Here we show that the C-terminal kinase domain of TRPM6 is cleaved from the channel domain in a cell type-specific fashion and is active. Cleavage requires that the channel conductance is functional. The cleaved kinase translocates to the nucleus, where it is strictly localized and phosphorylates specific histone serine and threonine (S/T) residues. TRPM6-cleaved kinases (M6CKs) bind subunits of the protein arginine methyltransferase 5 (PRMT5) molecular complex that make important epigenetic modifications by methylating histone arginine residues. Histone phosphorylation by M6CK results in a dramatic decrease in methylation of arginines adjacent to M6CK-phosphorylated amino acids. Knockout of

Indexed as

Gene Expression RegulationArginineCell LineHistonesHumansMethylationPhosphorylationProtein DomainsSerineThreonineTRPM Cation ChannelsArginineHistonesSerineThreonineTRPM6 protein, humanTRPM Cation Channelsion channelkinasePRMT5TRPM6TRPM7

Identifiers

PMID28784805
PMCPMC5576826
OpenAlexW2742500769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.